You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial

Citation Tools

Article menu
Oncolytic and local immunotherapy
Original research
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Coffman-D'Annibale K, Myojin Y, Monge C, et al
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial
Journal for ImmunoTherapy of Cancer 2024;12:e008079. doi: 10.1136/jitc-2023-008079